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The vision of its founding benefactor 
still animates the work of the Evans 
V O L U M E 3, N U M B E R 2 
S U M M E R 1987 
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T 
he Robert Dawson Evans 
M e m o r i a l Department of 
C l in ica l Research and Pre-
ventive Medic ine—to give 
the Evans its f u l l , off icial 
name—was dedicated on 
March 6, 1912. The department was estab-
lished w i t h a gif t f r o m Mrs . Maria A n t o i -
nette Evans as a memor ia l to her husband. 
Above the entrance to the Evans Bui lding 
was inscribed the personal credo of the do-
nor: " T r u t h Above Everything. " 
She set for th , as goals of the department, 
the f o l l o w i n g : 
• To seek improved methods for the preven-
t i o n of disease and for its al leviat ion and 
cure: C l in ica l Research. 
• To aid those w h o may prove w o r t h y i n 
their efforts to secure advanced education i n 
the medical sciences: Training. 
• To furnish i n s t r u c t i o n to the public i n the 
preservation of heal th: Public Education. 
Robert Dawson Evans, a colorful and vig-
orous businessman, had risen f r o m poverty 
to riches. Son of a Canadian seaman w h o had 
been lost at sea, young Evans and his f a m i l y 
moved to Boston. He fought i n the C i v i l War 
and, having been wounded twice i n the Bat-
tle of Bul l Run, returned to his first job, at a 
local rubber store, for $10 per week. 
Building an art collection 
W i t h i n a few years Evans had risen f r o m 
employee to president of his o w n rubber 
company, and he u l t i m a t e l y became one of 
the leaders of the rubber industry i n the 
U n i t e d States. I n the 1890s, however, Evans 
gave up his interests i n rubber and turned his 
energies to the creation of an even more l u -
crative career i n gold m i n i n g , i n the state of 
California. By the t u r n of the century, he was 
an established "captain of industry , " l i v i n g 
i n splendor i n his mansion at the corner of 
C o m m o n w e a l t h Avenue and Gloucester 
Street i n Boston. There, he pursued his inter-
est i n fine art, developing a notable collec-
t i o n of paintings. O n July 1, 1909, Evans 
was t h r o w n f r o m his horse w h i l e preparing 
his N o r t h Shore summer estate for a v is i t by 
President W i l l i a m Howard Taft. By July 4, i t 
was evident that he had suffered a ruptured 
viscus. He was taken to the Massachusetts 
Homeopathic Hospital , forerunner to the 
present Univers i ty Hospital . After a rapid 
d o w n h i l l course, he died on July 6, 1909. 
The Boston Evening Transcript, the lead-
ing Boston newspaper of i ts t ime, headlined 
his obituary, "Robert D . Evans dead—He 
came to Boston a poor hoy and amassed a 
fortune of $12,000,000." 
A memorial tribute 
As a t r ibute to Evans, his widow, Maria 
Antoinet te , donated to the Massachusetts 
Homeopathic Hospita l a medical research 
bui ld ing and an endowment of $100,000 to 
m a i n t a i n the research department. 
Over the next several years she made addi-
t ional gifts, and at her death, her estate was 
divided equally between the Evans Depart-
ment of C l in ica l Research and the Boston 
M u s e u m of Fine Arts . 
When the Evans Department was estab-
lished i n 1912 i t was one of the few i n s t i t u -
tions of its k i n d i n the w o r l d . C l in ica l 
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View from early 1960s shows 1942 Evans Building, 
Visible at left is East Newton Street Armory, then 
being used as athletic building by Boston-area stu-
dents. Part of armory's site was later used for new 
Evans Building, which was completed in 1972. 
investigation was carried on i n a number of 
hospitals and research facilities, hut separate 
departments of research were rare. A t the 
t ime of the department's founding, the mod-
ern scientific revolut ion and the advance of 
American research-oriented medicine were 
just beginning. Perhaps w i t h the advice of 
Dr. Frank C. Richardson, personal physician 
to the Evans f a m i l y and first director of the 
Evans, the purposes of the department were 
formulated hy Mrs . Evans i n a remarkably 
enlightened manner that was m u c h ahead of 
its t ime . 
A strong emphasis on research 
Mrs. Evans indicated that the "laboratories 
are to he maintained for research w o r k and 
restricted to such purposes. T w o floors of the 
bui lding are to be devoted exclusively to the 
care of patients under the treatment and ob-
servation of research workers. One additional 
floor is to he used as an a u d i t o r i u m for pur-
poses pertaining to research, preventive med-
icine and public education i n the preserva-
t ion of health. The Evans Department is not 
a hospital and must not he considered f r o m 
that standpoint as are those ins t i tut ions 
whose sole f u n c t i o n is the healing of the 
sick." 
Thus, f r o m its beginnings the Evans was 
designed to foster c l in ica l research by provid-
ing facilities and support for c l inic ian-
investigators w h o w o u l d conduct laboratory 
research directed toward the solut ion of c l in-
ical problems presented by patients under 
their care. 
The department was also intended f r o m its 
origin to educate the lay public about health 
and disease. W i t h i n a few days of the open-
ing of the Evans, a series of health talks was 
in i t ia ted for the general public . From the 
start, the Evans also funct ioned as a t ra ining 
fac i l i ty for c l in ica l investigators and stu-
dents, the latter through its connection 
(physical as w e l l as administrative) w i t h Bos-
ton Univers i ty School of Medicine. 
Contrihutions hy the Evans 
Over the past 75 years, the department has 
been home to hundreds of staff, w h o have 
carried out its pr ime mission of c l inical i n -
vestigation. A number of its physician-
scientists achieved internat ional recognition 
for their research advances. Examples w h i c h 
come readily to m i n d are Chester Reefer and 
Louis Weinstein i n infectious diseases; Rob-
ert W i l k i n s i n hypertension,- Franz Ingelfin-
ger i n gastroenterology; and A r n o l d Relman 
i n nephrology. Thousands of fellows, resi-
dents and medical students, moreover, have 
trained at the Evans. 
The original Evans Building, w h i c h now 
houses administrat ive offices of the School of 
Medicine and its School of Public Health, 
was succeeded i n 1942 hy a "new Evans." I n 
1972, the "new Evans," located on East 
N e w t o n Street near Harrison Avenue, was 
succeeded by the current Evans Building. 
This fac i l i ty today houses a staff of about 80 
M . D . and Ph.D. investigators,- more than half 
the patients under the care of the Univers i ty 
Hospital Department of Medicine; and the 
50 medical residents and 50-to-60 fel lows 
w h o are i n t ra in ing at the Evans. 
Over the past 75 years, the size of the staff 
has increased severalfold. The pace and vo l -
ume of medical research at the Evans have 
reached levels undreamt of i n 1912. St i l l , the 
original goals of the Evans—to discover 
" T r u t h Above Everything" f r o m scientific re-
search i n t o the causes, treatment and pre-
vent ion of h u m a n disease; to t ra in the next 
generation of medical investigators and sci-
entif ic cl inicians; and to educate the public 
about the f rui ts of medical research—these 
purposes are as va l id i n 1987 as they were i n 
1912. 
N o better f o r m u l a t i o n of the modus oper-
andi of the Evans can he offered than that 
w h i c h Dr. W i l k i n s , previous director of the 
Evans, wrote on the occasion of the depart-
ment's 50th anniversary: 
Dr. Wilkins's statement 
" A l l of these developments denote a broad-
ening of the interests and activities of the 
Evans M e m o r i a l beyond the strict l i m i t s of 
the Hospital or of the Department of Medi -
cine, to other parts of the Medical Center. 
Whi le due precautions w i l l he taken not to 
spread the Evans's resources too t h i n , nor to 
expand its activities beyond closely manage-
able proportions, further broadening of its 
scope may he expected. This is possible only 
because of strict adherence to t w o cardinal 
principles of Evans Policy: 
Continued on page 6 
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long an Evans tradition, 
today focuses on how 
vessels are damaged 
The history of hypertension research and 
treatment is i n t i m a t e l y hound up w i t h that 
of the Evans, especially over the depart-
ment's past four decades. 
To cite selected examples of key develop-
ments i n this area that have emerged f r o m 
the Evans: 
Robert W. W i l k i n s , M . D . , director of the 
Evans and the U H Department of Medicine 
f r o m 1960 to 1972, along w i t h his associates, 
was responsible for introducing i n the U n i t e d 
States the drug reserpine, the first effective 
anti-hypertensive medication. Dr. W i l k i n s , 
now retired and l i v i n g i n Newhuryport , 
Mass., also devised the step-care approach to 
hypertension treatment, i n w h i c h agents 
w i t h different mechanisms of action are 
comhined sequentially, as needed, i n order to 
control hypertension. 
I n 1957, Dr. W i l k i n s , W i l l i a m Hollander, 
M . D . , and A r a m V. Chohanian, M . D . , devel-
oped diuretic therapy for hypertension. This 
approach represented a major breakthrough, 
making possible the management of severe 
as w e l l as m i l d hypertension. 
The advances i n antihypertensive therapy 
have continued i n the past decade. Haramho-
los Gavras and his wife , Irene, both M.D.s 
and both members of the Evans Section of 
Hypertension and Atherosclerosis, collabo-
rated w i t h Dr. Chobanian on the develop-
ment of captopril , and subsequently enala-
p r i l . Both are angiotensin- inhihit ing 
enzymes, and they represent an excit ing d i -
rection i n therapy, providing what is now the 
most useful approach available for managing 
refractory hypertensives as w e l l as patients 
affected by congestive heart failure. 
Changing attitude toward treatment 
As these investigators and their counter-
parts at other ins t i tu t ions have been intro-
ducing an array of new treatments, medicine 
as a whole has undergone a marked change 
i n at t i tude toward hypertension therapy. 
" W h e n 1 first came here as a fe l low i n the 
late '50s, there was a very strong feeling i n 
some circles that lower ing blood pressure 
w o u l d be i n j u r i o u s , " recalls Dr. Chobanian, 
w h o heads the Evans Section of Hyperten-
sion and Atherosclerosis. 
Numerous studies, however, have since 
demonstrated that treating hypertension can 
be h ighly effective. 
The earliest studies, says Dr. Chobanian, 
showed that lower ing pressure is very benefi-
cial for individuals w i t h severe or malignant 
hypertension. " N i n e t y percent or more of 
those individuals w o u l d die w i t h i n a year 
w i t h o u t t reatment , " says the investigator, 
" b u t most of those w h o are treated medically 
survive . " 
Subsequent studies showed that therapy 
also offered important benefits for patients 
w i t h mi lder forms of hypertension, produc-
ing a marked reduction i n the incidence of 
strokes, and heart and kidney failure. 
Such findings have helped fuel widespread 
acceptance of the need for treatment. Yet 
w h i l e acceptance has grown, there is contro-
versy about some of the benefits of therapy 
for the mildest forms of hypertension, where 
the diastolic pressure is roughly between 90 
and 100. 
Coronary disease at issue 
"The big c l inical question r ight now is. 
W h y are we not getting a better reduction i n 
the incidence of coronary disease f r o m lower 
blood pressure?" says Dr. Chobanian. "We're 
preventing strokes and we're preventing 
heart failure, but most of the studies involv-
ing m i l d hypertensives indicate that we have 
only had a slight impact on coronary disease 
or overall m o r t a l i t y . " 
That concern has given new impetus to 
the basic research being pursued by Dr. 
Chobanian and his colleagues. Their inquir-
ies may help explain w h y treatment appar-
ently is not prolonging l i fe or reducing rates 
of myocardial infarc t ion i n individuals w i t h 
m i l d hypertension, and also may suggest new 
types of therapies. 
A consistent thread r u n n i n g through Dr. 
Chohanian's research interests is the mecha-
nisms by w h i c h the vessel w a l l is damaged. 
In the 1950s and 1960s, he, along w i t h Dr. 
Hol lander—now a BUSM professor of medi-
cine, biochemistry and physiology—and oth-
ers helped i l l u m i n a t e the factors that pro-
duce atherosclerotic plaques. The group 
showed that the key factors are the extent of 
penetration of cholesterol in to the arterial 
i n t i m a , metabolic activities w i t h i n arteries, 
and the effectiveness of the body's mecha-
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"When I first came 
here in the late '50s, 
there was a very 
strong feeling in 
some circles that 
lowering blood pres-
sure would be inju-
rious." 
Dr. Chobanian in his Cardiovascular Institute 
laboratory. 
Diagrams illustrate response to different types of insults. From left, they depict: 1., normal rat aorta; 2., 
aorta after six weeks exposure to elevated blood pressures, with thickened media, adherence of blood cells 
to intimal surface, and increased mitotic activity among smooth-muscle cells; and, 3., artery affected by 
both hypercholesterolemia and hypertension, with cell loss and platelet aggregation of endothelium, and 
accumulation of smooth-muscle and circulating blood cells in subendothelium. 
nisms for clearing the cholesterol once i t has 
entered the vessel w a l l . 
Studying arterial responses 
A m o n g Dr. Chohanian's chief current i n -
terests is how the artery w a l l responds to hy-
pertension. He and Peter I . Brecher, Ph.D., a 
professor of biochemistry at BUSM as w e l l as 
a member of the Evans, have helped shed 
l ight on one of the mechanisms by w h i c h 
blood pressure produces th ickening of the ar-
terial w a l l and hypertrophy of its smooth-
muscle cells. 
" F r o m w o r k that we and others have done 
i n the rat model, i t 's clear that the amount 
of D N A i n many of the arterial smooth-mus-
cle cells can double i n response to hyperten-
s ion , " says Dr. Chohanian. 
This phenomenon, called polyploidy, can 
occur w i t h i n a m o n t h of the t i m e that the 
animals ' pressures are raised, and a quarter 
or more of the smooth-muscle cells may be 
affected. "The cells seem to go into the 
g r o w t h cycle," says the investigator, " h u t for 
some reason they don't divide, so D N A 
builds up w i t h i n i n d i v i d u a l cells." 
The extent to w h i c h polyploidy is respon-
sible for the smooth-muscle hypertrophy that 
occurs i n arteries exposed to high blood pres-
sures is unclear, because smooth-muscle 
cells also become hypertrophic or hyperplas-
t ic i n the absence of D N A abnormalities. 
The findings about the D N A buildup, how-
ever, raise the possibi l i ty that genetic mal -
funct ioning may he implicated i n damage to 
arteries. 
A group w o r k i n g under Dr. Chohanian is 
exploring this possibil ity. Their specific focus 
is whether g r o w t h factors are somehow s t im-
ulated hy hypertension, and thus are partly 
to blame for the abnormal growth of cells i n 
artery walls affected by high blood pressure. 
Probing age-related damage 
Dr. Chobanian's investigations have i m p l i -
cations not only for the types of arterial hy-
pertrophy w i d e l y recognized as abnormal, 
but also for the arterial changes long re-
garded as a normal part of aging. 
The investigator says his studies related to 
the aging of vessels were st imulated i n part 
by some i n t r i g u i n g observations i n animals. 
" I f you look at the blood vessels f r o m young, 
hypertensive rats," he says, " y o u ' l l see that 
they often look v i r t u a l l y the same as vessels 
f r o m older, normotensive animals ." 
To test whether lowering pressures m i g h t 
prevent the hypertrophy and hyperplasia that 
underlies these changes. Dr. Chobanian and 
his associate Chris t ian Haudenschild, M . D . , 
a professor of pathology at BUSM, experi-
menta l ly reduced the pressures i n rats to the 
l o w normal range. The result was that arter-
ies f r o m the treated animals exhibited al-
most none of the changes normal ly associ-
ated w i t h aging. 
Does this mean that i t might be appropri-
ate to consider treating individuals w i t h pre-
sumably normal blood pressures? N o t yet, 
says Dr. Chobanian. " A t this point , we're 
really concerned w i t h the basic process that 
is going o n , " he notes. " I t w o u l d he a tre-
mendous step f r o m where we are now to he-
gin t a l k i ng about c l inical applications." 
Protecting the endothelium 
w h i l e the investigators' laboratory w o r k is 
Continued on page 6 
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Cardiovascular Institute: Focal point for hypertension studies 
Since 1974, m u c h of the hypertension research at Boston Univers i ty Medical Center has 
been carried out under the auspices of the Cardiovascular Inst i tute (CVI), w h i c h was 
founded that year by Dr. A r a m Chobanian. 
N o t long after its founding, the Inst i tute was designated a Specialized Center for Research 
i n Hypertension hy the Nat ional Institutes of Health. I t is one of five such centers i n the 
country. 
East year, the Nat iona l Institutes of Health named the CVI the first—and so far the 
o n l y — N a t i o n a l Research and Demonstrat ion Center for Hypertension. As such, i t has 
responsibilit ies that include not only carrying out basic and cl inical research, hut also 
developing new systems for the control of hypertension i n the c o m m u n i t y and exploring 
nat ional health-pol icy issues related to hypertension. • 
The 75th anniversary program: Come one, come all! 
The Evans w i l l m a r k its 75th anniversary 
w i t h a scientific program and gala celebra-
t i o n on Thursday and Friday, Oct. 29 and 30. 
A l l former Evans staff, fellows, residents 
and students are i n v i t e d to participate. The 
scientific program w i l l include 12 satellite 
symposia on recent advances i n internal 
medicine on Thursday, a series of "state-of-
the-art" lectures on Friday, and the D i s t i n -
guished Basic Science Lecture by Nobel lau-
reate Walter Gilbert , M . D . , professor of mo-
lecular biology at Harvard Medical School, 
also on Friday. The program is certified for 
cont inuing medical education credit and is 
open to Evans graduates and former fellows 
w i t h o u t charge. 
There w i l l be a reception at Boston's Park 
Plaza Hote l , site of the satellite symposia, on 
Satellite Symposia, Oct. 29, 1987 
Thursday after the symposia have concluded. 
O n Friday, there w i l l he a comhined lunch-
eon and "poster session" i n the BUSM's Hie-
hert Eounge. That day's plenary lectures w i l l 
he given i n the Evans Building's Keefer A u d i -
t o r i u m . There also w i l l be opportunities to 
vis i t the Hospital 's new A t r i u m Pavilion, a 
233-hed core c l inical fac i l i ty that w i l l have 
its grand opening i n November. 
For further i n f o r m a t i o n on the satellite 
symposia, please contact: 
Office of C o n t i n u i n g Medical Education 
Boston Univers i ty School of Medicine 
80 East Concord Street 
Boston, M A 02118 
(617) 638-4605 
Fol lowing are the faculty and topics for the 
symposia and the plenary lectures: 
E V A N S 
M E D I C I N E 
(Park Plaza Hotel) 
Title 
Current Views i n Cardiology 
Advances i n Hematology/ 
Oncology 
Gastroenterology at the Evans 
Fungal Infections and A n t i f u n -
gal Therapy 
A 30-Year Perspective on Car-
diovascular Epidemiology f r o m 
the Framingham Study 
Update i n Nephrology 
Progress i n Hypertension 
Recent Progress i n Selective 
Targeting of Cancer Cells 
Recent Advances i n Endocri-
nology 
Mechanisms of Cel l Act iva-
t i o n 
Special Topics for the Practic-
ing Internist 














Thomas J. Ryan, M . D . 
Eewis R. Weintraub, M . D . 
Ronald P. McCaffrey, M . D . 
J. Thomas EaMont, M . D . 
Richard Diamond, M . D . 
Joseph Stokes I I I , M . D . 
N o r m a n C. Levinsky, M . D . 
A r a m V. Chohanian, M . D . 
Ronald McCaffrey, M . D . 
John R. Murphy, Ph.D. 
James C. Melhy, M . D . 
David Center, M . D . 
David I . Beller, Ph.D. 
Robert Friedman, M . D . 
State-of-the-Art Lectures, Oct. 30,1987 
(Evans Bui lding, The Univers i ty Hospital) 
• Plagues of the T w e n t i e t h Century—Eouis Weinstein, M . D . , formerly chief of the Evans 
Section of Infectious Diseases,- professor of medicine, emeritus, Harvard Medical School. 
• Contr ibut ions of the Framingham Heart Study to the Conquest of Cardiovascular Plagues— 
W i l l i a m Kannel, M . D . , chief, Evans Section of Preventive Medicine and Epidemiology; pro-
fessor of medicine, Boston Univers i ty School of Medicine. 
• Gallstones: Observe, Obliterate or Operate—Martin C. Carey, M . D . , D.Sc; formerly Evans 
fe l low i n gastroenterology; Lawrence J. Henderson Associate Professor of Heal th Sciences 
and Technology, Harvard-M.I .T. D i v i s i o n of Heal th Sciences and Technology. 
Current Research at the Evans, poster session (Hiehert Lounge, BUSM) 
• Redesigning the Diphther ia T o x i n Structural Gene: Targeted Cytotoxins for Potential Ther-
peutic Use—John R. Murphy, Ph.D., chief, Evans Section of Biomolecular Medicine; re-
search professor of medicine, Boston Univers i ty School of Medicine. 
Distinguished Basic Science Lecture. Walter Gilbert, Ph.D., professor of molecular biology. 
Harvard Univers i ty . 
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Continued from page 2 
1. The insistence on excellence i n Evans 
personnel. 
2. The delegation of author i ty and respon-
s ib i l i ty to these h igh ly qualif ied persons for 
the development and financing (mainly 
through outside grants) of their o w n pro-
grams. 
" I n this way, Evans funds can be used to 
get new programs under way and to back 
them up i n times of emergency, hut can then 
be released to support other new activities 
that need development. 
"As always, there w i l l he insistence upon 
the principles that have contributed m u c h to 
the success of the Evans: Excellence and 
Freedom. Other than this, the location, f o r m 
and program of the Evans M e m o r i a l of the 
future w i l l he fiexihle and adaptable to the 
circumstances and needs of the future. Thus, 
the Evans Department of Cl in ica l Research 
w i l l cont inue to honor its name and to f u l f i l l 
its miss ion of service to the C o m m u n i t y and 
M a n k i n d . " 
The staff has grown, the buildings have 
been replaced by successively larger struc-
tures, but the raison d'etre of the department 
hegun by a w o m a n of foresight 75 years ago 
persists intact . • 
Hypertension... 
Continued from page 4 
s t i l l focused on hasic questions, i t is none-
theless taking directions that may eventually 
have important c l inical implicat ions . Some 
recent research, for example, has made use of 
propanolol, the heta blocker that is widely 
used to treat arrhythmias, angina and related 
conditions. 
" I n animal studies," says Dr. Chobanian, 
"we've found that w h e n you use a beta 
blocker l i k e propanolol, i t prevents the 
bui ldup of excess D N A i n response to hyper-
tension." Other studies, meanwhile , have 
shown that propanolol also prevents the for-
m a t i o n of atherosclerotic plaques i n rabbits 
on high-cholesterol diets. 
The studies support the hypothesis that 
the sympathetic nervous system's adrenergic 
pathways play a cr i t ical role i n the arterial 
wall 's response to injury. They also suggest, 
however, that other mechanisms are at w o r k 
as w e l l . One of the forms of propanolol ad-
ministered to the rabbits has l i t t l e effect on 
the beta adrenergic receptors at the relatively 
l o w doses employed. Yet i t , too, helped re-
tard plaque format ion . 
Dr. Chobanian says the effect may be re-
lated to the drug's stabil izing effects on cell 
membranes. "We t h i n k the propanolol is 
changing the permeabil i ty of the endothelial 
cells hy a local membrane effect," he ex-
plains, "so you don't get as m u c h cholesterol 
coming i n t o the ce l l . " 
Dr. Chohanian says that i n t ime, new ther-
apeutic approaches are l i k e l y to emerge f rom 
studies such as those under way i n his labo-
ratory. A l t h o u g h the nature of these ap-
proaches is not yet clear, he has some ideas 
about what directions they may take. 
"We w i l l he looking for approaches that do 
more than just lower blood pressure," he 
suggests. "That w i l l probably mean lowering 
serum cholesterol levels as wel l , for exam-
ple . " • 
Suggested further reading 
1. Chobanian, A .V. : Hypertension, antihyperten-
sive drugs, and atherogenesis: Mechanisms and 
cl inical impl ica t ions . J C l i n Hypert 2: 148s-157s, 
1986. 
2. Chobanian, A.V. , Brecher, P.I., Haudenschild, 
C.C.: Effects of hypertension and antihypertensive 
therapy on atherosclerosis. Hypertension 8; I- lS-I-
21, 1986. 
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